![origenis_logo_Pantone [Konvertiert]_2020](https://static.wixstatic.com/media/9afeac_83ea95f8f63144538d48a310b96d7f33~mv2.png/v1/fill/w_260,h_53,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/origenis_logo_Pantone%20%5BKonvertiert%5D_2020.png){kind=logo}
Gateway to Biotech: Top researchers met industry experts in the Faculty Club at IZB
- 16. Mai 2019
- 1 Min. Lesezeit
May 16, 2019
Michael Almstetter, CEO Origenis GmbH, explained what can be learned from progress in oncology in order to develop new treatments for Alzheimer’s and Parkinson’s disease.
